Resmed Inc. (RMD) concluded trading on Wednesday at a closing price of $173.83, with 3.0 million shares of worth about $522.09 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 23.07% during that period and on April 17, 2024 the price saw a loss of about -5.97%. Currently the company’s common shares owned by public are about 147.06M shares, out of which, 145.92M shares are available for trading.
However, the stock later moved at a day high price of 189.41, or with a loss of -5.97%. Stock saw a price change of -10.30% in past 5 days and over the past one month there was a price change of -8.97%. Year-to-date (YTD), RMD shares are showing a performance of 1.05% which decreased to -22.90% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $132.24 but also hit the highest price of $243.52 during that period. The average intraday trading volume for Resmed Inc. shares is 993.00K. The stock is currently trading -8.69% below its 20-day simple moving average (SMA20), while that difference is down -6.90% for SMA50 and it goes to 0.13% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Resmed Inc. (NYSE: RMD) currently have 147.06M outstanding shares and institutions hold larger chunk of about 56.90% of that.
The stock has a current market capitalization of $25.57B and its 3Y-monthly beta is at 0.69. PE ratio of stock for trailing 12 months is 28.80, while it has posted earnings per share of $6.04 in the same period. Its PEG reads 2.22 and has Quick Ratio of 1.89 while making debt-to-equity ratio of 0.31. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for RMD, volatility over the week remained 3.31% while standing at 2.28% over the month.
Stock’s fiscal year EPS is expected to rise by 15.74% while it is estimated to increase by 10.46% in next year. EPS is likely to shrink at an annualized rate of 13.00% for next 5-years, compared to annual growth of 22.66% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by KeyBanc Capital Markets on February 06, 2024 offering an Overweight rating for the stock and assigned a target price of $227 to it. Coverage by Morgan Stanley stated Resmed Inc. (RMD) stock as an Overweight in their note to investors on October 27, 2023, suggesting a price target of $169 for the stock. On October 12, 2023, RBC Capital Mkts Downgrade their recommendations, while on October 09, 2023, JP Morgan Upgrade their ratings for the stock with a price target of $170. Stock get a Peer perform rating from Wolfe Research on September 29, 2023.
